Invitrogen Scientist Settles Insider Trading Case

Law360, New York (May 2, 2008, 12:00 AM EDT) -- The U.S. Securities and Exchange Commission has settled a lawsuit alleging that a former scientist at biotech company Invitrogen Corp. engaged in insider trading based on information he obtained at a staff meeting.

The commission announced the settlement with Harry H. Yim on Thursday. Judge Irma E. Gonzalez of the U.S. District Court for the District of Southern California approved it on April 23.

Under the terms of the agreement, Yim is permanently enjoined from violating securities laws and will cough up $165,000, which includes paying...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.